293b cpd has been researched along with 1-methyl-3-isobutylxanthine in 1 studies
Studies (293b cpd) | Trials (293b cpd) | Recent Studies (post-2010) (293b cpd) | Studies (1-methyl-3-isobutylxanthine) | Trials (1-methyl-3-isobutylxanthine) | Recent Studies (post-2010) (1-methyl-3-isobutylxanthine) |
---|---|---|---|---|---|
100 | 0 | 16 | 5,148 | 5 | 279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brandis, M; Greger, R; Kuehr, J; Kunzelmann, K; Mall, M; Schreiber, R; Seydewitz, HH; Wissner, A | 1 |
1 other study(ies) available for 293b cpd and 1-methyl-3-isobutylxanthine
Article | Year |
---|---|
Role of K(V)LQT1 in cyclic adenosine monophosphate-mediated Cl(-) secretion in human airway epithelia.
Topics: 1-Methyl-3-isobutylxanthine; Amiloride; Biological Transport; Bronchi; Cell Line, Transformed; Chlorides; Chromans; Colforsin; Cyclic AMP; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diuretics; Gene Expression; Humans; KCNQ Potassium Channels; KCNQ1 Potassium Channel; Membrane Potentials; Patch-Clamp Techniques; Phosphodiesterase Inhibitors; Potassium; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Respiratory Mucosa; Sulfonamides | 2000 |